Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis

Yao Lu, Huijing Tang, Qianhua Fan, Ruiting Lan, Xiaoying Lin, Shuwei Zhang, Liyun Liu, Jianguo Xu · 2025

Read Eubacterium limosum modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis by Yao Lu, Huijing Tang, Qianhua Fan, Ruiting Lan, Xiaoying Lin, Shuwei Zhang, Liyun Liu, Jianguo Xu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12747957.txt.

Description

Yao Lu and co-authors published this 2025 study on a gut bacterium that calms inflamed intestines in mice. Inflammatory bowel disease has no cure, and the gut microbes clearly sway its course. The strain here is Eubacterium limosum, a gut native with anti-inflammatory hints, tested as strain El1405 against chemical colitis in mice.

Given the strain, sick mice scored lower on disease activity, kept longer colons, and showed milder tissue damage. Gene checks showed the gut mix shift, with several Bacteroides species and Akkermansia muciniphila gaining ground. Blood and colon measures of inflammatory signals fell, and metabolite checks traced products from the strain that fight swelling. The authors present the strain as a live drug lead worth more work.

Catalog record

CREATORYao Lu, Huijing Tang, Qianhua Fan, Ruiting Lan, Xiaoying Lin, Shuwei Zhang, Liyun Liu, Jianguo Xu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12747957

Browse the full library · About the Tower of Babel